Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramatroban + Montelukast in Atopic Asthma
NCT00311051Phase 3Withdrawn
- Sponsor
- Leibniz Lung Center
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Ramatroban + Montelukast with Montelukast + Placebo (2 arms). Primary endpoints: Lung function by spirometry and Allergen concentration for specific bronchoprovocation. Planned start Apr 2005; status: withdrawn.
02
Drugs
ramatroban
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00311051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311051.